(Q33917786)

30 July 2017

title

Effect of paricalcitol and cinacalcet on serum phosphate, FGF-23, and bone in rats with chronic kidney disease (English)

1 reference

30 July 2017

7

Eduardo Slatopolsky

1 reference

30 July 2017

2

Masanori Tokumoto

1 reference

30 July 2017

Jane L Finch

1

1 reference

30 July 2017

Hironori Nakamura

3

1 reference

30 July 2017

Wei Yao

4

1 reference

30 July 2017

Mohammad Shahnazari

5

1 reference

30 July 2017

Nancy Lane

6

1 reference

30 July 2017

publication date

3 March 2010

1 reference

American Journal of Physiology - Renal Physiology

30 July 2017

published in

1 reference

30 July 2017

volume

298

1 reference

30 July 2017

issue

6

1 reference

30 July 2017

page(s)

F1315-22

1 reference

The calcium sensing receptor is directly involved in both osteoclast differentiation and apoptosis

30 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886812

1alpha,25-Dihydroxyvitamin D3 upregulates FGF23 gene expression in bone: the final link in a renal-gastrointestinal-skeletal axis that controls phosphate transport

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886812

Cinacalcet hydrochloride is an effective treatment for secondary hyperparathyroidism in patients with CKD not receiving dialysis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886812

Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886812

Circulating FGF-23 is regulated by 1alpha,25-dihydroxyvitamin D3 and phosphorus in vivo

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886812

Novel aspects in regulated expression of the renal type IIa Na/Pi-cotransporter

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886812

FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886812

Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886812

Relative potencies of 1,25-(OH)(2)D(3) and 19-Nor-1,25-(OH)(2)D(2) on inducing differentiation and markers of bone formation in MG-63 cells.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886812

Pathogenesis of secondary hyperparathyroidism

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886812

Mouse osteoblastic cell line (MC3T3-E1) expresses extracellular calcium (Ca2+o)-sensing receptor and its agonists stimulate chemotaxis and proliferation of MC3T3-E1 cells

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886812

Calcimimetics with potent and selective activity on the parathyroid calcium receptor

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886812

Regulation of parathyroid cell proliferation.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886812

The hyperparathyroidism of chronic renal failure: a disorder of growth

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886812

Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886812

Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886812

Vitamin D: Metabolism and Biological Actions

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886812

Regulation by vitamin D metabolites of messenger ribonucleic acid for preproparathyroid hormone in isolated bovine parathyroid cells

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886812

Regulation by vitamin D metabolites of parathyroid hormone gene transcription in vivo in the rat.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886812

Reduced binding of [3H]1,25-dihydroxyvitamin D3 in the parathyroid glands of patients with renal failure

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886812

The noncalcemic analogue of vitamin D, 22-oxacalcitriol, suppresses parathyroid hormone synthesis and secretion

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886812

The effect of extracellular calcium elevation on morphology and function of isolated rat osteoclasts

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886812

Clinical counterpoint: vitamin D: new actions, new analogs, new therapeutic potential

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886812

Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis

5 July 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00552.2009

A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of cinacalcet HCl in participants with CKD not receiving dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00552.2009

Paricalcitol capsule for the treatment of secondary hyperparathyroidism in stages 3 and 4 CKD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00552.2009

Constitutive activity of the osteoblast Ca2+-sensing receptor promotes loss of cancellous bone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00552.2009

Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00552.2009

Serum phosphate levels and mortality risk among people with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00552.2009

The calcimimetic AMG 073 reduces parathyroid hormone and calcium x phosphorus in secondary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00552.2009

The calcimimetic AMG 073 as a potential treatment for secondary hyperparathyroidism of end-stage renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00552.2009

Efficacy of 19-Nor-1,25-(OH)2D2 in the prevention and treatment of hyperparathyroid bone disease in experimental uremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00552.2009

Impact of cinacalcet hydrochloride on bone histology in patients with secondary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00552.2009

An assessment of cinacalcet HCl effects on bone histology in dialysis patients with secondary hyperparathyroidism.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886812

Diminished parathyroid 1,25(OH)2D3 receptors in experimental uremia

29 October 2018

1 reference

12 December 2020

Direct inhibitory effect of calcitriol on parathyroid function (sigmoidal curve) in dialysis

1 reference

12 December 2020

The effect of 22-oxacalcitriol on serum calcitriol

1 reference

12 December 2020

A new analog of calcitriol, 19-nor-1,25-(OH)2D2, suppresses parathyroid hormone secretion in uremic rats in the absence of hypercalcemia

1 reference

12 December 2020

Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism

1 reference

12 December 2020

The calcimimetic NPS R-568 decreases plasma PTH in rats with mild and severe renal or dietary secondary hyperparathyroidism

1 reference

12 December 2020

1,25-(OH)2D receptors are decreased in parathyroid glands from chronically uremic dogs

1 reference

12 December 2020

1 alpha, 25-dihydroxyvitamin D3 specific regulation of growth, morphology, and fibronectin in a human osteosarcoma cell line

1 reference

12 December 2020

Suppression by 1,25(OH)2D3 of transcription of the pre-proparathyroid hormone gene

1 reference

12 December 2020

Calcium-sensing receptor in mature osteoclasts, which are bone resorbing cells

1 reference

12 December 2020

10.1152/AJPRENAL.00552.2009

Identifiers

DOI

1 reference

30 July 2017

1 reference

30 July 2017

1 reference